20:38 , Mar 12, 2019 |  BC Extra  |  Company News

UC strengthens CRISPR IP position with new patent

The USPTO issued a third patent covering fundamental aspects of the CRISPR-Cas9 technology to The Regents of the University of California, the University of Vienna and Emmanuelle Charpentier, strengthening the group's patent position in the...
22:33 , Feb 8, 2019 |  BC Extra  |  Company News

USPTO to grant UC foundational CRISPR patent

A notice of allowance on a core CRISPR patent application will put IP covering the most foundational aspects of the game-changing gene editing technology in the hands of two rival parties. The Regents of the...
03:31 , Dec 7, 2018 |  BC Innovations  |  Tools & Techniques

Germline editing gets technical

As the smoke clears from Jiankui He’s bombshell germline editing announcement, the gap between where the gene editing field is now and where it would need to be to support responsible germline editing has become...
19:59 , Nov 2, 2018 |  BC Week In Review  |  Company News

UC Regents issued second CRISPR patent in U.S.

The Regents of the University of California, the University of Vienna and Emmanuelle Charpentier were granted a patent by the U.S. Patent Office covering use of guide RNA formats in CRISPR-Cas9 gene editing technology. The...
20:37 , Oct 30, 2018 |  BC Extra  |  Company News

UC Regents issued second CRISPR patent in U.S.

The Regents of the University of California, the University of Vienna and Emmanuelle Charpentier were granted a patent by the U.S. Patent Office covering use of guide RNA formats in CRISPR-Cas9 gene editing technology. The...
00:20 , Sep 11, 2018 |  BC Extra  |  Company News

CRISPR ruling means legal fight will continue

A ruling by the U.S. Court of Appeals for the Federal Circuit promises to extend the legal battle over which party owns the use of CRISPR in eukaryotic cells. In another victory for The Broad...
18:09 , Jun 22, 2018 |  BC Week In Review  |  Company News

UC Regents get CRISPR guide RNA patent in U.S.

The U.S. Patent Office on June 19 granted a patent related to CRISPR-Cas9 gene editing technology to the Regents of the University of California, the University of Vienna and Emmanuelle Charpentier covering use of guide...
22:40 , Jun 19, 2018 |  BC Extra  |  Company News

UC Regents issued CRISPR-Cas9 guide RNA patent in U.S.

The U.S. Patent Office on Tuesday granted a patent related to CRISPR-Cas9 gene editing technology to the Regents of the University of California, the University of Vienna and Emmanuelle Charpentier covering use of guide RNA...
22:48 , May 3, 2018 |  BC Extra  |  Company News

Management tracks: Achillion, Sangamo

Rare disease company Achillion Pharmaceuticals Inc. (NASDAQ:ACHN) said CEO Milind Deshpande will step down. He will be succeeded by President and COO Joseph Truitt. Sangamo Therapeutics Inc. (NASDAQ:SGMO) said SVP and CBO Curt Herberts, III...
22:01 , Sep 28, 2017 |  BC Innovations  |  Tools & Techniques

Proofreading the editors

The threat of off-target edits has spurred CRISPR companies to build in quality control systems from the earliest stages of drug development. Editas Medicine Inc. thinks its Uni-Directional Targeted Sequencing methodology, dubbed “UDiTaS,” will detect...